Found 18 matching trials
Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59 PHASE2 The main purpose of this study is to assess the ability of H5 influenza vir...
Show More Learn More & Join Trial
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older PHASE2 Study to evaluate the safety and immunogenicity of H7N9 antigen in combinat...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant PHASE1 Background:
\- Adjuvants are substances included in vaccines that stimulat...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 PHASE2 This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Show More Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Learn More & Join Trial
H5N1 Mix and Match With AS03 PHASE1 Approximately 216, and up to 240, healthy males and non-pregnant females, 1...
Show More Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Learn More & Join Trial
2013/2017 H7N9 Prime-Boost Interval PHASE2 This is a trial designed to assess the safety, reactogenicity and immunogen...
Show More Location
Emory Children's Center - Pediatric Infectious Diseases
Learn More & Join Trial
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response PHASE4 The study is a prospective single site exploratory study to examine the imp...
Show More Location
The Hope Clinic of Emory University
Learn More & Join Trial
H7N9 Mix and Match With AS03 and MF59 in Healthy Adults PHASE2 This Phase II randomized, double-blinded, controlled study in up to 1000 ma...
Show More Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Learn More & Join Trial
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) PHASE2 This study will compare the different immune responses to Influenza A (H5N1...
Show More Location
The Hope Clinic - Emory Vaccine Center
Learn More & Join Trial
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine PHASE1 Groups 1 to 3 will receive two vaccinations on Day 0 and Day 21. Group 1 wi...
Show More Location
Privatklinik Leech
Learn More & Join Trial